Cited by 262Multiple Sclerosis Research StudiesTreatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.

Depression in multiple sclerosis

Patten, Scott B., Marrie, Ruth Ann, Carta, Mauro G.·2017·International Review of Psychiatry

DOI 10.1080/09540261.2017.1322555

Open this paper in CoChat — free account

Abstract

Depressive disorders occur in up to 50% of people living with multiple sclerosis (MS). Prevalence estimates are generally 2-3-times higher than those of the general population. Myriad aetiologic factors may contribute to the aetiology of depression in MS including biological mechanisms (e.g. hippocampal microglial activation, lesion burden, regional atrophy), as well as the stressors, threats, and losses that accompany living with an unpredictable and often disabling disease. Some prominent risk factors for depression such as (younger) age, (female) sex, and family history of depression are less consistently associated with depression in MS than they are in the general population. Management of depression in MS has not been well studied, but available data on detection and treatment align with general principles of depression management. While the validity of standard measurement scales has often been questioned, available evidence suggests that standard scales provide valid ratings. Evidence for the effectiveness of depression treatments in MS is limited, but available evidence supports the effectiveness of standard treatment approaches, including both cognitive behavioural therapies and antidepressant medications.

Integrity signals

Registry

Crossref · 10.1080/09540261.2017.1322555

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Validation and Utility of a Self-report Version of PRIME-MD<SUBTITLE>The PHQ Primary Care Study</SUBTITLE>
Spitzer, R. L. (1999) · JAMA · doi:10.1001/jama.282.18.1737 · Cited by 9,802
The Epidemiology of Major Depressive Disorder: Results From the National Comorbidity Survey Replication (NCS-R)
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
The PHQ-9: A New Depression Diagnostic and Severity Measure
Kroenke, K., & Spitzer, R. L. (2002) · Psychiatric Annals · doi:10.3928/0048-5713-20020901-06 · Cited by 5,898 · cited 2×
“…samples from clinical settings or volunteer community samples, a recent national survey conducted in Canada used the Brief Patient Health Questionnaire (Kroenke & Spitzer, 2002; Spitzer, Kroenke, Williams, & Group, 1999), or PHQ-9, in a probability sample representative of the household population.”
Method
A Diagnostic Interview
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686
Screening for Depression in Well Older Adults: Evaluation of a Short Form of the CES-D
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · American Journal of Preventive Medicine · doi:10.1016/s0749-3797(18)30622-6 · Cited by 5,403
The World Mental Health (WMH) Survey Initiative version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI)
Kessler, R. C., & Üstün, T. B. (2004) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.168 · Cited by 4,771
Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale).
Andresen, E. M., Malmgren, J. A., Carter, W. B., & Patrick, D. L. (1994) · PubMed · Cited by 4,426
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942 · cited 1×
“Inflammatory changes are implicated in the aetiology of depression generally (Miller & Raison, 2016), providing another set of candidate mechanisms that may link depression to MS (Feinstein et al., 2014).”
Background
The world health organization composite international diagnostic interview short-form (CIDI-SF)
Kessler, R. C., Andrews, G., Mroczek, D., Ustun, B., & Wittchen, H. (1998) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.47 · Cited by 2,242
Prevalence of mental disorders in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project
The ESEMeD/MHEDEA 2000 Investigators, Alonso, J., Angermeyer, M. C., Bernert, S., Bruffaerts, R., Brugha, T. S., Bryson, H., de Girolamo, G., de Graaf, R., Demyttenaere, K., et al. (2004) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0047.2004.00327.x · Cited by 1,825
International Journal of Methods in Psychiatric Research
Bhugra, D., Bhui, K. S., Desai, M., Singh, J., & Baldwin, D. (2006) · International Journal of Methods in Psychiatric Research · doi:10.1002/(issn)1557-0657 · Cited by 1,492
THE NATURAL HISTORY OF MULTIPLE SCLEROSIS: A GEOGRAPHICALLY BASED STUDY: I. CLINICAL COURSE AND DISABILITY
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
Screening for Depression in the General Population with the Center for Epidemiologic Studies Depression (CES-D): A Systematic Review with Meta-Analysis
Vilagut, G., Forero, C. G., Barbaglia, G., & Alonso, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155431 · Cited by 1,053
Interferon beta‐lb in the treatment of multiple sclerosis
The IFNB Multiple Sclerosis Study Group and the University of British Columbia MS/MRI Analysis Group (1995) · Neurology · doi:10.1212/wnl.45.7.1277 · Cited by 971
National Collaborating Centre for Mental Health
Veale, D. M. (2006) · Research Portal (King's College London) · Cited by 941
The hospital anxiety and depression scale
Snaith, R. P., & Zigmond, A. S. (1986) · BMJ · doi:10.1136/bmj.292.6516.344 · Cited by 879
Depressive Symptoms and Severity of Illness in Multiple Sclerosis: Epidemiologic Study of a Large Community Sample
Chwastiak, L., Ehde, D. M., Gibbons, L. E., Sullivan, M., Bowen, J. D., & Kraft, G. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.11.1862 · Cited by 555
The link between multiple sclerosis and depression
Feinstein, A., Magalhaes, S., Richard, J., Audet, B., & Moore, C. S. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.139 · Cited by 550
Depression and multiple sclerosis
Sadovnick, A. D., Remick, R. A., Allen, J. B., Swartz, E. S., Yee, I. M. L., Eisen, K., Farquhar, R., Hashimoto, S. A., Hooge, J. P., Kastrukoff, L. F., et al. (1996) · Neurology · doi:10.1212/wnl.46.3.628 · Cited by 536
Major depression in multiple sclerosis
Patten, S. B., Beck, C. A., Williams, J. V. A., Barbui, C., & Metz, L. M. (2003) · Neurology · doi:10.1212/01.wnl.0000095964.34294.b4 · Cited by 534
Self-citation
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review
Marrie, R. A., Reingold, S., Cohen, J., Stuve, O., Trojano, M., Sorensen, P. S., Cutter, G., & Reider, N. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514564487 · Cited by 519
Self-citation
Multiple Sclerosis: A Review
Goldenberg, M. M. (1973) · BMJ · doi:10.1136/bmj.2.5863.432 · Cited by 488
Descriptive Epidemiology of Major Depression in Canada
Patten, S. B., Wang, J. L., Williams, J. V., Currie, S., Beck, C. A., Maxwell, C. J., & el-Guebaly, N. (2006) · The Canadian Journal of Psychiatry · doi:10.1177/070674370605100204 · Cited by 443
Self-citation
Affective Disorders in Multiple Sclerosis Review and Recommendations for Clinical Research
Minden, S. L., & Schiffer, R. B. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530010124031 · Cited by 415
Mood Disorder and Multiple Sclerosis
Joffe, R. T., Lippert, G. P., Gray, T. A., Sawa, G. M., & Horvath, Z. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520160018007 · Cited by 387
Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis
Benedict, R. H. B., Fishman, I., McClellan, M., Bakshi, R., & Weinstock‐Guttman, B. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms902oa · Cited by 336
Comparative outcomes for individual cognitive-behavior therapy, supportive-expressive group psychotherapy, and sertraline for the treatment of depression in multiple sclerosis.
Mohr, D. C., Boudewyn, A. C., Goodkin, D. E., Bostrom, A., & Epstein, L. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.6.942 · Cited by 334
The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1162oa · Cited by 329
Diagnostic conversion from depression to bipolar disorders: results of a long-term prospective study of hospital admissions
Angst, J., Sellaro, R., Stassen, H. H., & Gamma, A. (2003) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00195-2 · Cited by 311
Treatment of Depression Improves Adherence to Interferon Beta-1b Therapy for Multiple Sclerosis
Mohr, D. C., Goodkin, D., Likosky, W., Gatto, N. M., Baumann, K. A., & Rudick, R. A. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550170015009 · Cited by 306
Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis
Udina, M., Castellví, P., Moreno-España, J., Navinés, R., Valdés, M., Forns, X., Langohr, K., Solà, R., Vieta, E., & Martín-Santos, R. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07694 · Cited by 297
Depression in multiple sclerosis.
Minden, S., Orav, J., & Reich, P. (1987) · General Hospital Psychiatry · doi:10.1016/0163-8343(87)90052-1 · Cited by 267
Adjustment to multiple sclerosis: Application of a stress and coping model.
Pakenham, K. I. (1999) · Health Psychology · doi:10.1037//0278-6133.18.4.383 · Cited by 265
Comparing CESD-10, PHQ-9, and PROMIS depression instruments in individuals with multiple sclerosis.
Amtmann, D., Kim, J., Chung, H., Bamer, A. M., Askew, R. L., Wu, S., Cook, K. F., & Johnson, K. L. (2014) · Rehabilitation Psychology · doi:10.1037/a0035919 · Cited by 259
Telephone-administered cognitive-behavioral therapy for the treatment of depressive symptoms in multiple sclerosis.
Mohr, D. C., Likosky, W., Bertagnolli, A., Goodkin, D. E., Wende, J. V. D., Dwyer, P., & Dick, L. P. (2000) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.68.2.356 · Cited by 240
Health-related quality of life in multiple sclerosis
Berrigan, L. I., Fisk, J. D., Patten, S. B., Tremlett, H. L., Wolfson, C. M., Warren, S., Fiest, K. M., McKay, K. A., Marrie, R. A., For the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS), et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002564 · Cited by 236
Self-citation
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology
Minden, S. L., Feinstein, A., Kalb, R. C., Miller, D., Mohr, D. C., Patten, S. B., Bever, C., Schiffer, R. B., Gronseth, G. S., & Narayanaswami, P. (2014) · Neurology · doi:10.1212/wnl.0000000000000013 · Cited by 230
Self-citation
Diagnosis and treatment of multiple sclerosis
Murray, T. J. (2006) · BMJ · doi:10.1136/bmj.332.7540.525 · Cited by 219
Antidepressant pharmacotherapy of depression associated with multiple sclerosis
Schiffer, R. B., & WINEMAN, N. M. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.11.1493 · Cited by 200
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis
Fiest, K. M., Walker, J. R., Bernstein, C. N., Graff, L. A., Zarychanski, R., Abou-Setta, A. M., Patten, S. B., Sareen, J., Bolton, J. M., Marriott, J. J., et al. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2015.10.004 · Cited by 198
Self-citation
Adjustment Disorder: epidemiology, diagnosis and treatment
Carta, M., Balestrieri, M., Murru, A., & Hardoy, M. (2009) · Clinical Practice and Epidemiology in Mental Health · doi:10.1186/1745-0179-5-15 · Cited by 193
Self-citation
Descriptive Epidemiology of Major Depressive Disorder in Canada in 2012
Patten, S. B., Williams, J. V. A., Lavorato, D. H., Wang, J. L., McDonald, K., & Bulloch, A. G. M. (2015) · The Canadian Journal of Psychiatry · doi:10.1177/070674371506000106 · Cited by 190
Self-citation
Exercise training improves depressive symptoms in people with multiple sclerosis: Results of a meta-analysis
Ensari, I., Motl, R. W., & Pilutti, L. A. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.03.014 · Cited by 182
Cognitive behavioural therapy for the treatment of depression in people with multiple sclerosis: a systematic review and meta-analysis
Hind, D., Cotter, J., Thake, A., Bradburn, M., Cooper, C., Isaac, C., & House, A. (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-5 · Cited by 180
Biopsychosocial correlates of lifetime major depression in a multiple sclerosis population
Patten, S. B., Metz, L. M., & Reimer, M. A. (2000) · Multiple Sclerosis Journal · doi:10.1177/135245850000600210 · Cited by 171
Self-citation
Suicide among Danes with multiple sclerosis
Brønnum‐Hansen, H. (2005) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.056747 · Cited by 154
Differences in the burden of psychiatric comorbidity in MS vs the general population
Marrie, R. A., Fisk, J. D., Tremlett, H. L., Wolfson, C. M., Warren, S., Tennakoon, A., Leung, S., & Patten, S. B. (2015) · Neurology · doi:10.1212/wnl.0000000000002174 · Cited by 150
Self-citation
Hippocampal Neuroinflammation, Functional Connectivity, and Depressive Symptoms in Multiple Sclerosis
Colasanti, A., Guo, Q., Giannetti, P., Wall, M. B., Newbould, R. D., Bishop, C., Onega, M., Nicholas, R. S., Ciccarelli, O., Muraro, P. A., et al. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.022 · Cited by 148
An online programme to reduce depression in patients with multiple sclerosis: a randomised controlled trial
Fischer, A., Schröder, J., Vettorazzi, E., Wolf, O. T., Pöttgen, J., Lau, S., Heesen, C., Moritz, S., & Gold, S. M. (2015) · The Lancet Psychiatry · doi:10.1016/s2215-0366(14)00049-2 · Cited by 143
Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis
Sacco, R., Santangelo, G., Stamenova, S., Bisecco, A., Bonavita, S., Lavorgna, L., Trojano, L., d’Ambrosio, A., Tedeschi, G., & Gallo, A. (2016) · European Journal of Neurology · doi:10.1111/ene.12932 · Cited by 140
Exercise as an add-on strategy for the treatment of major depressive disorder: a systematic review
Mura, G., Moro, M. F., Patten, S. B., & Carta, M. G. (2014) · CNS Spectrums · doi:10.1017/s1092852913000953 · Cited by 127
Self-citation
Depression associated with multiple sclerosis
Feinstein, A., & Feinstein, K. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00298-6 · Cited by 119
The effect of exercise on depressive symptoms in multiple sclerosis based on a meta‐analysis and critical review of the literature
Dalgas, U., Stenager, E., Sloth, M., & Stenager, E. (2014) · European Journal of Neurology · doi:10.1111/ene.12576 · Cited by 119
Validation of Mood Measures for People with Multiple Sclerosis
Watson, T. M., Ford, E., Worthington, E. J., & Lincoln, N. B. (2014) · International Journal of MS Care · doi:10.7224/1537-2073.2013-013 · Cited by 112
Efficacy of paroxetine in treating major depressive disorder in persons with multiple sclerosis
Ehde, D. M., Kraft, G. H., Chwastiak, L., Sullivan, M. D., Gibbons, L. E., Bombardier, C. H., & Wadhwani, R. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.08.002 · Cited by 107
Pharmacologic treatment of depression in multiple sclerosis
Koch, M. W., Glazenborg, A., Uyttenboogaart, M., Mostert, J., & De Keyser, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007295.pub2 · Cited by 105
Multiple Sclerosis, interferon beta-1b and depression
Feinstein, A., O’Connor, P., & Feinstein, K. (2002) · Journal of Neurology · doi:10.1007/s00415-002-0725-0 · Cited by 103
The acceptability of computerised cognitive behavioural therapy for the treatment of depression in people with chronic physical disease: A qualitative study of people with multiple sclerosis
Hind, D., O’Cathain, A., Cooper, C. L., Parry, G. D., Isaac, C. L., Rose, A., Martin, L., & Sharrack, B. (2010) · Psychology & Health · doi:10.1080/08870440902842739 · Cited by 101
Do antidepressants increase the risk of mania and bipolar disorder in people with depression? A retrospective electronic case register cohort study
Patel, R., Reiss, P., Shetty, H., Broadbent, M. T. M., Stewart, R. J., McGuire, P. K., & Taylor, M. J. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-008341 · Cited by 101
Diffusion tensor imaging abnormalities in depressed multiple sclerosis patients
Feinstein, A., O'Connor, P. W., Akbar, N., Moradzadeh, L., Scott, C. J. M., & Lobaugh, N. (2010) · Multiple Sclerosis · doi:10.1177/1352458509355461 · Cited by 100
Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis
Minden, S. L., Orav, J., & Schildkraut, J. J. (1988) · Neurology · doi:10.1212/wnl.38.10.1631 · Cited by 93
Multiple sclerosis and psychiatric disorders: Comorbidity and sibling risk in a nationwide Swedish cohort
Johansson, V., Lundholm, C., Hillert, J. A., Masterman, T., Lichtenstein, P., Landén, M., & Hultman, C. M. (2014) · Multiple Sclerosis Journal · doi:10.1177/1352458514540970 · Cited by 91
Alcohol and drug abuse among persons with multiple sclerosis
Bombardier, C., Blake, K., Ehde, D., Gibbons, L., Moore, D., & Kraft, G. (2004) · Multiple Sclerosis · doi:10.1191/1352458504ms989oa · Cited by 89
Validity of four screening scales for major depression in MS
Patten, S. B., Burton, J., Fiest, K. M., Wiebe, S., Bulloch, A. G., Koch, M. W., Dobson, K. S., Metz, L. M., Maxwell, C. J., & Jetté, N. (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458514559297 · Cited by 88
Self-citation
Depression in multiple sclerosis: a longitudinal analysis.
Beal, C. C., Stuifbergen, A., & Brown, A. (2007) · Archives of Psychiatric Nursing · doi:10.1016/j.apnu.2007.02.008 · Cited by 87
Depression in multiple sclerosis: A long-term longitudinal study
Koch, M., Patten, S., Berzins, S., Zhornitsky, S., Greenfield, J., Wall, W., & Metz, L. (2015) · Multiple Sclerosis · doi:10.1177/1352458514536086 · Cited by 86
Self-citation
Interferon β-1a and depression in relapsing - remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial
Patten, S. B., & Metz, L. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700406 · Cited by 83
Self-citation
Interferon β1a and depression in secondary progressive MS: Data from the SPECTRIMS Trial
Patten, S. B., & Metz, L. M. (2002) · Neurology · doi:10.1212/wnl.59.5.744 · Cited by 82
Self-citation
The relationship between depression and interferon beta-1a therapy in patients with multiple sclerosis
Patten, S. B., Francis, G., Metz, L. M., Lopez-Bresnahan, M. V., Chang, P., & Curtin, F. (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1144oa · Cited by 81
Self-citation
Multiple sclerosis and depression: influence of interferon b therapy
Zéphir, H., Seze, J. D., Stojkovic, T., Delisse, B., Ferriby, D., Cabaret, M., & Vermersch, P. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms915oa · Cited by 73
Depressive symptoms in a treated multiple sclerosis cohort
Patten, S. B., Fridhandler, S., Beck, C. A., & Metz, L. M. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms960oa · Cited by 69
Self-citation
Oral fingolimod (FTY720) in relapsing multiple sclerosis: impact on health-related quality of life in a phase II study
Montalbán, X., Comi, G., O'Connor, P. W., Gold, S. M., de Vera, A., Eckert, B., & Kappos, L. (2011) · Multiple Sclerosis · doi:10.1177/1352458511411061 · Cited by 69
The association of depression with disease course in multiple sclerosis
Zabad, R. K., Patten, S. B., & Metz, L. M. (2005) · Neurology · doi:10.1212/01.wnl.0000149760.64921.aa · Cited by 69
Self-citation
The risk of Bipolar Disorders in Multiple Sclerosis.
Carta, M., Moro, M., Lorefice, L., Trincas, G., Cocco, E., del Giudice, E., Fenu, G., Colom, F., & Marrosu, M. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.11.008 · Cited by 66
Self-citation
Longitudinal epidemiology of major depression as assessed by the Brief Patient Health Questionnaire (PHQ-9)
Patten, S. B., & Schopflocher, D. (2009) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2008.05.012 · Cited by 65
Self-citation
Depressive Symptoms Correlate with Disability and Disease Course in Multiple Sclerosis Patients: An Italian Multi-Center Study Using the Beck Depression Inventory
Solaro, C. M., Trabucco, E., Signori, A., Martinelli, V., Radaelli, M., Centonze, D., Rossi, S., Grasso, M. G., Clemenzi, A., Bonavita, S., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160261 · Cited by 64
Quality of life in multiple sclerosis (MS) and role of fatigue, depression, anxiety, and stress: A bicenter study from north of Iran.
(2014) · PubMed Central · Cited by 56
Multiple sclerosis and alcohol: a study of problem drinking
Quesnel, S., & Feinstein, A. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms992oa · Cited by 52
Personal and family history of affective illness in patients with multiple sclerosis
Joffe, R. T., Lippert, G. P., Gray, T. A., Sawa, G. M., & Horvath, Z. (1987) · Journal of Affective Disorders · doi:10.1016/0165-0327(87)90062-0 · Cited by 52
Multiple sclerosis and risk of attempted and completed suicide – a cohort study
Brenner, P., Burkill, S. M., Jokinen, J., Hillert, J. A., Bahmanyar, S., & Montgomery, S. (2016) · European Journal of Neurology · doi:10.1111/ene.13029 · Cited by 50
Incidence and course of depression in multiple sclerosis in the multinational BEYOND trial
Schippling, S., O'Connor, P. W., Knappertz, V. A., Pohl, C., Bogumil, T., Suarez, G., Cook, S. D., Filippi, M., Hartung, H.-P., Comı, G., et al. (2016) · Journal of Neurology · doi:10.1007/s00415-016-8146-8 · Cited by 49
Multiple sclerosis and bipolar disorders: The burden of comorbidity and its consequences on quality of life
Carta, M. G., Moro, M. F., Lorefice, L., Picardi, A., Trincas, G., Fenu, G., Cocco, E. E., Floris, F., Bessonov, D., Akiskal, H. S., et al. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.05.024 · Cited by 47
Self-citation
Validation study of prevalence and correlates of depressive symptomatology in multiple sclerosis
Bamer, A. M., Cetin, K., Johnson, K., Gibbons, L. E., & Ehde, D. M. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2008.04.006 · Cited by 47
Prevalence and risk factors for suicidal ideation in a multiple sclerosis population
Viner, R., Patten, S. B., Berzins, S. A., Bulloch, A. G. M., & Fiest, K. M. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.12.010 · Cited by 47
Self-citation
Moclobemide Treatment in Multiple Sclerosis Patients With Comorbid Depression
Barak, Y., Ur, E., & Achiron, A. (1999) · Journal of Neuropsychiatry · doi:10.1176/jnp.11.2.271 · Cited by 47
Clinical correlates of CES-D depressive symptom ratings in an MS population
Patten, S. B., Lavorato, D. H., & Metz, L. M. (2005) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2005.06.010 · Cited by 43
Self-citation
Adverse health behaviours are associated with depression and anxiety in multiple sclerosis: A prospective multisite study
McKay, K. A., Tremlett, H. L., Fisk, J. D., Patten, S. B., Fiest, K. M., Berrigan, L. I., Marrie, R. A., & for the CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS) (2015) · Multiple Sclerosis Journal · doi:10.1177/1352458515599073 · Cited by 42
Self-citation
The assessment of depression in people with multiple sclerosis: a systematic review of psychometric validation studies
Hind, D., Kaklamanou, D., Beever, D., Webster, R., Lee, E. C., Barkham, M., & Cooper, C. L. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0931-5 · Cited by 41
Prophylactic Antidepressant Treatment of Interferon-Induced Depression in Chronic Hepatitis C
Udina, M., Hidalgo, D., Navinés, R., Forns, X., Sola, R. L., Farré, M., Capuron, L., Vieta, E., & Martín‐Santos, R. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13r08800 · Cited by 40
Duloxetine Is Effective in Treating Depression in Multiple Sclerosis Patients
Solaro, C. M., Bergamaschi, R., Rezzani, C., Mueller, M., Trabucco, E., Bargiggia, V., Dematteis, F., Mattioda, A., Cimino, V., Restivo, D. A., et al. (2013) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3182996400 · Cited by 39
Point prevalence and correlates of depression in a national community sample with multiple sclerosis
Viner, R., Fiest, K. M., Bulloch, A. G. M., Williams, J. V. A., Lavorato, D. H., Berzins, S. A., Jetté, N., Metz, L. M., & Patten, S. B. (2014) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2013.12.011 · Cited by 36
Self-citation
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial
Hunter, S. F., Agius, M. A., Miller, D. M., Cutter, G., Barbato, L., McCague, K., Meng, X., Agashivala, N., Chin, P., & Hollander, E. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.03.024 · Cited by 34
Interferon beta treatment of multiple sclerosis
Klapper, J. A. (1994) · Neurology · doi:10.1212/wnl.44.1.188-a · Cited by 34
Challenges in screening for depression in multiple sclerosis
Patten, S. B., Berzins, S., & Metz, L. M. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510377770 · Cited by 33
Self-citation
Depression and hypomania symptoms are associated with high dose corticosteroids treatment for MS relapses
Morrow, S. A., Barr, J., Rosehart, H., & Ulch, S. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2015.08.040 · Cited by 24
Progressive multiple sclerosis and mood disorders
Lorefice, L., Fenu, G., Trincas, G., Moro, M. F., Frau, J., Coghe, G., Cocco, E. E., Marrosu, M. G., & Carta, M. G. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2220-3 · Cited by 21
Self-citation
Combination treatment of fingolimod with antidepressants in relapsing–remitting multiple sclerosis patients with depression: a multicentre, open-label study – REGAIN
Bayas, A., Schuh, K., Baier, M. L., Vormfelde, S. V., for the REGAIN Study Group, Koppai-Reiner, J., Strauss, E., Haerting, B., Wiehler, S., Boehringer, J., et al. (2016) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285616651197 · Cited by 20
Assessment of Depression in Multiple Sclerosis
Crawford, P., & Webster, N. J. (2009) · International Journal of MS Care · doi:10.7224/1537-2073-11.4.167 · Cited by 13
Welcome to ICD-10
Bebbington, P. (1992) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/bf00788894 · Cited by 10
Organic mood disorder: a valid psychiatry consultation diagnosis?
Yates, W. R., Wesner, R. B., & Thompson, R. (1991) · Journal of Affective Disorders · doi:10.1016/0165-0327(91)90081-3 · Cited by 9
Hippocampal Neuroinflammation and Depression: Relevance to Multiple Sclerosis and Other Neuropsychiatric Illnesses
Manning, K. J. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.05.001 · Cited by 9
Patients with multiple sclerosis do not necessarily consume more alcohol or tobacco than the general population
Fragoso, Y. D., Gomes, S., Gonçalves, M. V. M., Machado, S. C. N., Morales, R. R., de Oliveira, F. T. M., de Oliveira, J. F., Olmo, N. R. S., Parolin, M. K. F., Siquineli, F., et al. (2015) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20150117 · Cited by 5

Research works printed but not linked: 7

First M., 1997, Structured clinical interview for DSM-IV Axis I disorders. Research version, non-patient edition (SCID-I/NP)
Goldenberg M.M., 2012, p T, 37, 175
10.1037//0022-006X.69.6.942 · DOI · Paper page
10.1037/0022-006X.68.2.356 · DOI · Paper page
10.1037/0278-6133.18.4.383 · DOI
10.1191/135245800678827536 · DOI
Salehpoor G., 2014, Iranian Journal of Nursing and Midwifery Research, 19, 593

Sorted by citations

The Bidirectional Relationship of Depression and Inflammation: Double Trouble
Beurel, E., Toups, M., & Nemeroff, C. B. (2020) · Neuron · doi:10.1016/j.neuron.2020.06.002 · Cited by 2,136
Major depressive disorder
Marx, W., Penninx, B. W. J. H., Solmi, M., Furukawa, T. A., Firth, J., Carvalho, A. F., & Berk, M. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00454-1 · Cited by 910
Pragmatism as a paradigm for patient‐oriented research
Allemang, B. A., Sitter, K. C., & Dimitropoulos, G. (2021) · Health Expectations · doi:10.1111/hex.13384 · Cited by 243
Using the SF-36 measure to compare the health impact of multiple sclerosis and Parkinson's disease with normal population health profiles
Riazi, A. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.710 · Cited by 135
New Insights into the Pivotal Role of the Amygdala in Inflammation-Related Depression and Anxiety Disorder
Hu, P., Lü, Y., Pan, B., & Zhang, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911076 · Cited by 139

See all 262

Authors: Patten, S. B., Marrie, R. A., & Carta, M. G.
Affiliations: University of Calgary (CA)
University of Manitoba (CA)
University of Cagliari (IT)
Corresponding author: Patten, Scott B.
ORCID: Patten, Scott B.
Marrie, Ruth Ann
Carta, Mauro G.
Venue: International Review of Psychiatry
Publisher: Informa UK Limited
Published: 2017-07-06
Volume: 29
Issue: 5
Pages: 463-472
ISSN: 0954-0261 (ISSN-L)
1369-1627
DOI: 10.1080/09540261.2017.1322555
OpenAlex: W2726625509
Cited by: 262
References: 103
Citations by year: 2026: 16 · 2025: 22 · 2024: 34 · 2023: 33 · 2022: 43 · 2021: 34 · 2020: 57 · 2019: 11 · 2018: 7 · 2017: 2
FWCI: 3.36
Type: journal article
Language: en
Open access: closed
Locations: International Review of Psychiatry (publishedVersion)
PubMed (publishedVersion)
UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion, public-domain)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
Keywords: depression, multiple sclerosis, prevalence, etiology, lesion burden, brain atrophy, stressors, risk factors, depression screening, depression treatment, cognitive behavioral therapy, antidepressants, measurement scales
MeSH terms: Adult, Antidepressive Agents, Depression, Female, Humans, Male, Multiple Sclerosis, Brief Psychiatric Rating Scale, Cognitive Behavioral Therapy, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Depression in multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks